FDA Should Consider Pearson Model for Qualified Claims– NNFA
This article was originally published in The Tan Sheet
FDA needs to explore testing more specific, expanded qualified health claims language as suggested in the Pearson vs. Shalala decision, according to the National Nutritional Foods Association
You may also be interested in...
FDA may look to health claim statements developed and tested by FTC as it continues working toward effective use of the claims in product labeling, Deputy Commissioner for Medical & Scientific Affairs Scott Gottlieb, MD, indicated during a recent speech to industry
"FDA should rescind its approval of all qualified health claims and impose a moratorium on the approval of additional qualified claims" that do not meet significant scientific agreement standards, the Center for Science in the Public Interest argued following a presentation of consumer research on health claims
American Longevity will file a lawsuit against FDA no later than Dec. 9 in response to the agency's denial of qualified health claims tying lycopene-containing dietary supplements to cancer risk reduction